2023 Inhalers Pipeline Research Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies

News provided by

Jan 17, 2024, 13:00 ET

DUBLIN, Jan. 17, 2024 /PRNewswire/ -- The "Inhalers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" report has been added to ResearchAndMarkets.com's offering.

Inhalers Pipeline Report provides comprehensive information about the Inhalers pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Inhaler devices deliver medication to the lungs.

The comprehensive report provides in-depth coverage of the rapidly evolving field of Inhalers, offering a thorough analysis of various aspects. It meticulously reviews the intricate details of major pipeline products, including comprehensive product descriptions, licensing agreements, collaborative efforts, and other pivotal developmental activities shaping the landscape of inhalers.

Furthermore, the report conducts a comprehensive examination of the major players actively driving innovation in Inhalers, presenting an extensive catalog of their ongoing pipeline projects. This coverage spans the entire spectrum of development stages, ranging from early conceptualization to products in the approved and issued stages, providing a holistic view of the dynamic field of inhaler development.

Additionally, the report offers essential clinical trial data related to ongoing trials associated with these pipeline products, ensuring stakeholders are well-informed about the latest advancements in this crucial healthcare sector. It also keeps a keen eye on recent developments within the inhalers segment and the broader industry, ensuring that stakeholders stay up-to-date with the latest trends and breakthroughs in inhaler technology and healthcare delivery.

Reasons to Buy

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Inhalers under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Inhalers Overview

3 Products under Development
3.1 Inhalers - Pipeline Products by Stage of Development
3.2 Inhalers - Pipeline Products by Segment
3.3 Inhalers - Pipeline Products by Territory
3.4 Inhalers - Pipeline Products by Regulatory Path
3.5 Inhalers - Pipeline Products by Estimated Approval Date
3.6 Inhalers - Ongoing Clinical Trials

4 Inhalers - Pipeline Products under Development by Companies
4.1 Inhalers Companies - Pipeline Products by Stage of Development
4.2 Inhalers - Pipeline Products by Stage of Development

5 Inhalers Companies and Product Overview

6 Inhalers- Recent Developments

7 Appendix

A selection of companies mentioned in this report includes

1nhaler Ltd
Acorda Therapeutics Inc
Advent Pharmaceuticals Pty Ltd
Aerami Therapeutics Inc
Aespira Ltd.
AKELA Pharma Inc. (Inactive)
AsMedic Ltd.
Bayer AG
Bellerophon Therapeutics Inc
Cambridge Healthcare Innovations Ltd
Cipla Ltd
Covinhaler LLP
Creare LLC
De Motu Cordis Pty Ltd
DMK Pharmaceuticals Corp
Drexel University
Eli Lilly and Co
Engage Therapeutics Inc
Findair Sp zoo
FocusStart LLC
Glenmark Pharmaceuticals Ltd
GSK plc
Hovione Technology Ltd
Iconovo AB
Lupin Pharmaceuticals Inc
MannKind Corp
Medihale Ltd (Inactive)
Monash University
Nektar Therapeutics
North Carolina State University
Novartis AG
Ology Bioservices Inc
OPKO Health Inc
OtiTopic Inc
Pai Life Sciences Inc
Phargentis SA
Pharmaxis Ltd
Pneuma Respiratory Inc
Pure Scientific Technologies Inc
PureIMS BV
Quench Medical Inc
Resolve Digital Health Inc
Respira Therapeutics Inc
Respirent Pharmaceuticals Co Ltd
Rhinomed Ltd
Sandoz International GmbH
Seng Vital International GmbH
Sheffield Hallam University
Shin Nippon Biomedical Laboratories Ltd
Sinsin Pharmaceutical Co Ltd
Softhale NV
Spyryx Biosciences Inc (Inactive)
Teva Pharmaceutical Industries Ltd
Transpire Bio Inc
University of Kansas
University of Sydney
University of Texas Medical Branch at Galveston
Uscom Ltd
Vectura Group Plc
Veoli Ltd
Verona Pharma Plc
Virginia Commonwealth University

For more information about this report visit https://www.researchandmarkets.com/r/3awdnp

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets